Aspen records 15% year-on-year revenue increase
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded consistently positive results for the period ended December 2007. Revenue increased by 15
Aspen and Strides Enter Into Broad and Strategic Partnership
Johannesburg South Africa, and Bangalore, India: Aspen Pharmacare (Aspen), Africa’s largest pharmaceutical manufacturer and the largest generics manufacturer in the southern hemisphere, has entered into
Aspen operating profit exceeds R1bn
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has announced a sound set of results for the financial year ended June 30, 2007.
Aspen Scientific and Technical capabilities provide strong export growth potential
JSE listed Aspen (APN), Africa and the Southern hemisphere’s largest pharmaceutical manufacturer, has hosted the Honourable Minister Mosibudi Mangena, MP, South African Minister of Science
Key ARV Products Viread® and Truvada® Registered by MCC
JSE listed Aspen, a leading global manufacturer and distributor of anti-retroviral (ARV) medicines, today announced that it has been granted certification from the Medicines Control
Aspen and Strides enter into broad and strategic partnership
Johannesburg South Africa, and Bangalore, India: Aspen Pharmacare (Aspen), Africa’s largest pharmaceutical manufacturer and the largest generics manufacturer in the southern hemisphere, has entered into
Aspen records 15% increase in revenue
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded positive results for the period ended December 2006. Revenue increased by 15 percent
Once-offs results in 235% increase in HEPS
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has announced impressive results for the financial year ended June 30, 2006. These are the
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
